Travelling abroad to access cell therapies not available or affordable at home.
Travelling abroad for stem-cell treatments unavailable or unapproved in your home country—often to clinics in Mexico, Costa Rica, or Eastern Europe. Patients typically seek this for conditions where home regulators haven't approved any cell therapy (spinal injury, Parkinson's). The appeal is understandable, but risks are real: clinics may lack rigorous quality controls, outcomes aren't tracked systematically, and if complications arise abroad, your home medical team may not know how to manage them. Before booking, ask the clinic for third-party quality certification, published outcomes (not just testimonials), and whether your home insurance will cover follow-up care.
Médecine régénérative certifiée GMP au cœur de l'UE — à partir de 3 000–8 000 €, une fraction des prix américains ou allemands. Protocoles personnalisés pour patients de plus de 50 pays.
Évaluation médicale gratuite